Search research articles
Contact Us
Filters
Showing results (91-100 of 113) with videos related to
Page
of 12
Sort By:
Cancer Research
|
August 17, 2001
Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines
N Keshelava, J J Zuo, P Chen, et al.
Medical and Pediatric Oncology
|
December 7, 2000
Multidrug resistance-associated protein 1 (MRP1) expression in neuroblastoma cell lines and primary tumors
H Goto, N Keshelava, K K Matthay, et al.
International Journal of Cancer
|
May 10, 1991
Alpha-smooth-muscle actin and desmin expressions in human neuroblastoma cell lines
T Sugimoto, H Ueyama, H Hosoi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
Double-alkylator non-total-body irradiation regimen with autologous hematopoietic stem-cell transplantation in pediatric solid tumors
M F Ozkaynak, K Matthay, M Cairo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1996
Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies
D O Stram, K K Matthay, M O'Leary, et al.
Journal of the National Cancer Institute
|
May 18, 1994
Hsp27 expression in neuroblastoma: correlation with disease stage
D R Ungar, N Hailat, J R Strahler, et al.
Progress in Clinical and Biological Research
|
January 1, 1988
Bone marrow transplantation for poor prognosis neuroblastoma
R C Seeger, T J Moss, S A Feig, et al.
Progress in Clinical and Biological Research
|
January 1, 1991
Response of neuroblastoma to retinoic acid in vitro and in vivo
C P Reynolds, D J Kane, P A Einhorn, et al.
British Journal of Pharmacology
|
October 18, 2016
Amino acid transporter SLC6A14 is a novel and effective drug target for pancreatic cancer
V Coothankandaswamy, S Cao, Y Xu, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
January 1, 1994
Treatment of neuroblastoma patients with antiganglioside GD2 antibody plus interleukin-2 induces antibody-dependent cellular cytotoxicity against neuroblastoma detected in vitro
J A Hank, J Surfus, J Gan, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 113) with videos related to
Sort By:
Page
of 12
Cancer Research
|
August 17, 2001
Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines
N Keshelava, J J Zuo, P Chen, et al.
Medical and Pediatric Oncology
|
December 7, 2000
Multidrug resistance-associated protein 1 (MRP1) expression in neuroblastoma cell lines and primary tumors
H Goto, N Keshelava, K K Matthay, et al.
International Journal of Cancer
|
May 10, 1991
Alpha-smooth-muscle actin and desmin expressions in human neuroblastoma cell lines
T Sugimoto, H Ueyama, H Hosoi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
Double-alkylator non-total-body irradiation regimen with autologous hematopoietic stem-cell transplantation in pediatric solid tumors
M F Ozkaynak, K Matthay, M Cairo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1996
Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies
D O Stram, K K Matthay, M O'Leary, et al.
Journal of the National Cancer Institute
|
May 18, 1994
Hsp27 expression in neuroblastoma: correlation with disease stage
D R Ungar, N Hailat, J R Strahler, et al.
Progress in Clinical and Biological Research
|
January 1, 1988
Bone marrow transplantation for poor prognosis neuroblastoma
R C Seeger, T J Moss, S A Feig, et al.
Progress in Clinical and Biological Research
|
January 1, 1991
Response of neuroblastoma to retinoic acid in vitro and in vivo
C P Reynolds, D J Kane, P A Einhorn, et al.
British Journal of Pharmacology
|
October 18, 2016
Amino acid transporter SLC6A14 is a novel and effective drug target for pancreatic cancer
V Coothankandaswamy, S Cao, Y Xu, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
January 1, 1994
Treatment of neuroblastoma patients with antiganglioside GD2 antibody plus interleukin-2 induces antibody-dependent cellular cytotoxicity against neuroblastoma detected in vitro
J A Hank, J Surfus, J Gan, et al.
Page
of 12